Published in Arthritis Rheum on October 15, 2008
Benefits of exercise in rheumatoid arthritis. J Aging Res (2011) 1.25
Enhanced reactivity to pain in patients with rheumatoid arthritis. Arthritis Res Ther (2009) 1.16
Infliximab therapy increases body fat mass in early rheumatoid arthritis independently of changes in disease activity and levels of leptin and adiponectin: a randomised study over 21 months. Arthritis Res Ther (2010) 1.09
Rheumatoid cachexia: a complication of rheumatoid arthritis moves into the 21st century. Arthritis Res Ther (2009) 0.99
Muscle density in rheumatoid arthritis: associations with disease features and functional outcomes. Arthritis Rheum (2012) 0.94
Muscle strength, muscle mass, and physical disability in women with systemic lupus erythematosus. Arthritis Care Res (Hoboken) (2015) 0.93
The effects of strength and endurance training in patients with rheumatoid arthritis. Clin Rheumatol (2010) 0.91
Moderators of the negative effects of catastrophizing in arthritis. Pain Med (2010) 0.89
Metabolic syndrome in rheumatoid arthritis: case control study. BMC Musculoskelet Disord (2013) 0.89
Sex differences in assessment of obesity in rheumatoid arthritis. Arthritis Care Res (Hoboken) (2013) 0.89
Progression of coronary artery atherosclerosis in rheumatoid arthritis: comparison with participants from the Multi-Ethnic Study of Atherosclerosis. Arthritis Res Ther (2013) 0.87
Muscle Strength and Changes in Physical Function in Women With Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken) (2015) 0.85
Patellar tendon properties and lower limb function in rheumatoid arthritis and ankylosing spondylitis versus healthy controls: a cross-sectional study. ScientificWorldJournal (2013) 0.81
Protective effect of methotrexate in patients with rheumatoid arthritis and cardiovascular comorbidity. Ther Adv Musculoskelet Dis (2012) 0.78
Body composition of rheumatoid arthritis patients in the City of Cape Town, South Africa. Clin Rheumatol (2013) 0.78
Are persons with rheumatoid arthritis deconditioned? A review of physical activity and aerobic capacity. BMC Musculoskelet Disord (2012) 0.76
Sarcopenia in rheumatoid arthritis: prevalence, influence of disease activity and associated factors. Rheumatol Int (2017) 0.75
Workability and Muscle Strength in Patients With Seropositive Rheumatoid Arthritis: Survey Study Protocol. JMIR Res Protoc (2017) 0.75
Indicators of walking speed in rheumatoid arthritis: relative influence of articular, psychosocial, and body composition characteristics. Arthritis Care Res (Hoboken) (2015) 0.75
Impact of intensive treatment and remission on health-related quality of life in early and established rheumatoid arthritis. RMD Open (2016) 0.75
A close association of body cell mass loss with disease activity and disability in Chinese patients with rheumatoid arthritis. Clinics (Sao Paulo) (2011) 0.75
Physical Fitness of the Arms in Patients with Rheumatic Diseases. Iran J Public Health (2016) 0.75
Increased extracellular water measured by bioimpedance and by increased serum levels of atrial natriuretic peptide in RA patients-signs of volume overload. Clin Rheumatol (2016) 0.75
Frailty and reduced physical function go hand in hand in adults with rheumatoid arthritis: a US observational cohort study. Clin Rheumatol (2017) 0.75
A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis (1987) 174.79
The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum (1988) 111.05
Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest (1995) 9.59
Assessment of habitual physical activity by a seven-day recall in a community survey and controlled experiments. Am J Epidemiol (1985) 6.10
Strength, but not muscle mass, is associated with mortality in the health, aging and body composition study cohort. J Gerontol A Biol Sci Med Sci (2006) 6.08
How to read radiographs according to the Sharp/van der Heijde method. J Rheumatol (1999) 3.07
Total-body skeletal muscle mass: estimation by a new dual-energy X-ray absorptiometry method. Am J Clin Nutr (2002) 2.96
Measuring function in rheumatoid arthritis: Identifying reversible and irreversible components. Arthritis Rheum (2006) 2.75
Body composition in healthy aging. Ann N Y Acad Sci (2000) 2.66
The measurement structure of the Center for Epidemiologic Studies Depression Scale. J Pers Assess (1995) 2.39
Percentage of body fat and body mass index are associated with mobility limitations in people aged 70 and older from NHANES III. J Am Geriatr Soc (2002) 2.06
Physical disability and muscular strength in relation to obesity and different body composition indexes in a sample of healthy elderly women. Int J Obes Relat Metab Disord (2004) 2.05
Rheumatoid cachexia: cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation. J Clin Invest (1994) 2.01
The clinical value of the Stanford Health Assessment Questionnaire Functional Disability Index in patients with rheumatoid arthritis. J Rheumatol (1988) 1.99
High body fatness, but not low fat-free mass, predicts disability in older men and women: the Cardiovascular Health Study. Am J Clin Nutr (1998) 1.82
Prevalence and predictors of disability in valued life activities among individuals with rheumatoid arthritis. Ann Rheum Dis (2005) 1.77
A reappraisal of HAQ disability in rheumatoid arthritis. Arthritis Rheum (2000) 1.61
Long-term outcome in rheumatoid arthritis: a simple algorithm of baseline parameters can predict radiographic damage, disability, and disease course at 12-year followup. Arthritis Rheum (2002) 1.55
Health assessment questionnaire score is the best predictor of 5-year quality of life in early rheumatoid arthritis. J Rheumatol (2006) 1.53
Rheumatoid cachexia: depletion of lean body mass in rheumatoid arthritis. Possible association with tumor necrosis factor. J Rheumatol (1992) 1.52
Cachexia in rheumatoid arthritis. Int J Cardiol (2002) 1.47
Cost of musculoskeletal diseases: impact of work disability and functional decline. J Rheumatol Suppl (2003) 1.43
Mortality predictors among 263 patients with rheumatoid arthritis. J Rheumatol (1991) 1.35
Productivity costs among patients with rheumatoid arthritis: the influence of methods and sources to value loss of productivity. Ann Rheum Dis (2005) 1.21
Disability and health-related quality of life among patients with rheumatoid arthritis: association with radiographic joint damage, disease activity, pain, and depressive symptoms. Scand J Rheumatol (2006) 1.14
Body composition in rheumatoid arthritis. Br J Rheumatol (1997) 1.10
Pain and joint mobility explain individual subdimensions of the health assessment questionnaire (HAQ) disability index in patients with rheumatoid arthritis. Ann Rheum Dis (2004) 1.06
Early functional disability predicts both all-cause and cardiovascular mortality in people with inflammatory polyarthritis: results from the Norfolk Arthritis Register. Ann Rheum Dis (2006) 1.01
Comparison between women and men with recent onset rheumatoid arthritis of disease activity and functional ability over two years (the TIRA project). Ann Rheum Dis (2003) 0.97
Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial. Arthritis Rheum (2004) 6.22
Myths, presumptions, and facts about obesity. N Engl J Med (2013) 5.39
Etanercept versus methotrexate in patients with early rheumatoid arthritis: two-year radiographic and clinical outcomes. Arthritis Rheum (2002) 4.15
A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: the treatment of Early Aggressive Rheumatoid Arthritis Trial. Arthritis Rheum (2012) 4.01
Predictors of joint damage in patients with early rheumatoid arthritis treated with high-dose methotrexate with or without concomitant infliximab: results from the ASPIRE trial. Arthritis Rheum (2006) 3.29
Ten putative contributors to the obesity epidemic. Crit Rev Food Sci Nutr (2009) 2.71
Longterm safety, efficacy, and radiographic outcome with etanercept treatment in patients with early rheumatoid arthritis. J Rheumatol (2005) 2.40
Serum levels of insulin-like growth factor-I (IGF-I) and dehydroepiandrosterone sulfate (DHEA-S), and their relationships with serum interleukin-6, in the geriatric syndrome of frailty. Aging Clin Exp Res (2004) 2.17
Association of vitamin D with cardiometabolic risk factors in rheumatoid arthritis. Arthritis Care Res (Hoboken) (2012) 2.10
Insulin resistance in rheumatoid arthritis: disease-related indicators and associations with the presence and progression of subclinical atherosclerosis. Arthritis Rheumatol (2015) 2.07
'I'm hurting, I want to kill myself': rheumatoid arthritis flare is more than a high joint count--an international patient perspective on flare where medical help is sought. Rheumatology (Oxford) (2011) 1.92
Concomitant leflunomide therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (2002) 1.84
Randomized trial of the effect of drug presentation on asthma outcomes: the American Lung Association Asthma Clinical Research Centers. J Allergy Clin Immunol (2009) 1.81
Objective physical activity measurement in the osteoarthritis initiative: Are guidelines being met? Arthritis Rheum (2011) 1.81
Longitudinal predictors of progression of carotid atherosclerosis in rheumatoid arthritis. Arthritis Rheum (2011) 1.72
Increased prevalence of carotid artery atherosclerosis in rheumatoid arthritis is artery-specific. J Rheumatol (2010) 1.69
Left ventricular structure and function in patients with rheumatoid arthritis, as assessed by cardiac magnetic resonance imaging. Arthritis Rheum (2010) 1.63
Are overweight and obese adults with arthritis being advised to lose weight? J Clin Rheumatol (2007) 1.63
Tumor necrosis factor inhibitor therapy and risk of serious postoperative orthopedic infection in rheumatoid arthritis. Arthritis Rheum (2006) 1.57
An evaluation of risk factors for major adverse cardiovascular events during tocilizumab therapy. Arthritis Rheumatol (2015) 1.57
Obesity and quality of life: mediating effects of pain and comorbidities. Obes Res (2003) 1.52
Hormone replacement therapy and its relationship to lipid and glucose metabolism in diabetic and nondiabetic postmenopausal women: results from the Third National Health and Nutrition Examination Survey (NHANES III). Diabetes Care (2002) 1.51
Association of autoimmunity to peptidyl arginine deiminase type 4 with genotype and disease severity in rheumatoid arthritis. Arthritis Rheum (2008) 1.48
Abnormal body composition phenotypes in older rheumatoid arthritis patients: association with disease characteristics and pharmacotherapies. Arthritis Rheum (2008) 1.45
Physiological mechanisms of sex differences in exertional dyspnoea: role of neural respiratory motor drive. Exp Physiol (2013) 1.44
Toward the reduction of population obesity: macrolevel environmental approaches to the problems of food, eating, and obesity. Psychol Bull (2007) 1.37
Infliximab treatment maintains employability in patients with early rheumatoid arthritis. Arthritis Rheum (2006) 1.36
Coronary arterial calcification in rheumatoid arthritis: comparison with the Multi-Ethnic Study of Atherosclerosis. Arthritis Res Ther (2009) 1.33
Assessing physical activity in persons with knee osteoarthritis using accelerometers: data from the osteoarthritis initiative. Arthritis Care Res (Hoboken) (2010) 1.30
Adiponectin is a mediator of the inverse association of adiposity with radiographic damage in rheumatoid arthritis. Arthritis Rheum (2009) 1.30
Knee osteoarthritis compromises early mobility function: The Women's Health and Aging Study II. J Rheumatol (2003) 1.25
Yoga for arthritis: a scoping review. Rheum Dis Clin North Am (2010) 1.25
Overweight, obesity, and colorectal cancer screening: disparity between men and women. BMC Public Health (2004) 1.24
BMI and headache among women: results from 11 epidemiologic datasets. Obesity (Silver Spring) (2008) 1.24
Pain sensitivity and pain reactivity in osteoarthritis. Arthritis Care Res (Hoboken) (2010) 1.21
Abdominal adiposity in rheumatoid arthritis: association with cardiometabolic risk factors and disease characteristics. Arthritis Rheum (2010) 1.21
Relationship between body weight gain and significant knee, hip, and back pain in older Americans. Obes Res (2003) 1.20
Environmental tobacco smoke exposure and nocturnal symptoms among inner-city children with asthma. J Allergy Clin Immunol (2002) 1.19
The association between depression, lung function, and health-related quality of life among adults with cystic fibrosis. Chest (2007) 1.18
Changes in lipoproteins associated with methotrexate or combination therapy in early rheumatoid arthritis: results from the treatment of early rheumatoid arthritis trial. Arthritis Rheum (2013) 1.18
Impact of interview mode on accuracy of child and parent report of adherence with asthma-controller medication. Pediatrics (2007) 1.17
Serious infections associated with anticytokine therapies in the rheumatic diseases. J Intensive Care Med (2004) 1.15
The relationship of actigraph accelerometer cut-points for estimating physical activity with selected health outcomes: results from NHANES 2003-06. Res Q Exerc Sport (2012) 1.14
Do asthma medication beliefs mediate the relationship between minority status and adherence to therapy? J Asthma (2008) 1.14
Myocardial dysfunction in rheumatoid arthritis: epidemiology and pathogenesis. Arthritis Res Ther (2005) 1.13
Golimumab. Nat Rev Drug Discov (2009) 1.11
Prevalence of traditional modifiable cardiovascular risk factors in patients with rheumatoid arthritis: comparison with control subjects from the multi-ethnic study of atherosclerosis. Semin Arthritis Rheum (2012) 1.10
Safety and efficacy of etanercept beyond 10 years of therapy in North American patients with early and longstanding rheumatoid arthritis. Arthritis Care Res (Hoboken) (2010) 1.09
Association of circulating adiponectin levels with progression of radiographic joint destruction in rheumatoid arthritis. Ann Rheum Dis (2011) 1.08
The case for an international patient-reported outcomes measurement information system (PROMIS®) initiative. Health Qual Life Outcomes (2013) 1.08
Significance of preradiographic magnetic resonance imaging lesions in persons at increased risk of knee osteoarthritis. Arthritis Rheumatol (2014) 1.07
How common is hip pain among older adults? Results from the Third National Health and Nutrition Examination Survey. J Fam Pract (2002) 1.07
Association of body fat with C-reactive protein in rheumatoid arthritis. Arthritis Rheum (2008) 1.06
The relationship of race/ethnicity and social class to hormone replacement therapy: results from the Third National Health and Nutrition Examination Survey 1988-1994. Menopause (2002) 1.06
Conclusion of "Nordic walking for geriatric rehabilitation: a randomized pilot trial" is based on faulty statistical analysis and is inaccurate. Disabil Rehabil (2015) 1.06
Identifying preliminary domains to detect and measure rheumatoid arthritis flares: report of the OMERACT 10 RA Flare Workshop. J Rheumatol (2011) 1.05
Correlates of exercise adherence in an African American church community. Cultur Divers Ethnic Minor Psychol (2002) 1.05
The effects of intentional weight loss as a latent variable problem. Stat Med (2005) 1.04
Are health care professionals advising adults with arthritis to become more physically active? Arthritis Rheum (2005) 1.03
Obesity and other modifiable factors for physical inactivity measured by accelerometer in adults with knee osteoarthritis. Arthritis Care Res (Hoboken) (2013) 1.02
Reappraisal of OMERACT 8 draft validation criteria for a soluble biomarker reflecting structural damage endpoints in rheumatoid arthritis, psoriatic arthritis, and spondyloarthritis: the OMERACT 9 v2 criteria. J Rheumatol (2009) 1.00
Establishing a core domain set to measure rheumatoid arthritis flares: report of the OMERACT 11 RA flare Workshop. J Rheumatol (2014) 1.00
Transitions to mobility difficulty associated with lower extremity osteoarthritis in high functioning older women: longitudinal data from the Women's Health and Aging Study II. Arthritis Rheum (2006) 0.99
The ILAR-East Africa initiative: current needs and progress in the globalization of rheumatology. Clin Rheumatol (2010) 0.99
Differences in demographic, behavioral, and biological variables between those with valid and invalid accelerometry data: implications for generalizability. J Phys Act Health (2012) 0.97
Daily spiritual experiences of older adults with and without arthritis and the relationship to health outcomes. Arthritis Rheum (2008) 0.97
T cell polarization identifies distinct clinical phenotypes in scleroderma lung disease. Arthritis Rheum (2008) 0.96
"Stiffness has different meanings, I think, to everyone": examining stiffness from the perspective of people living with rheumatoid arthritis. Arthritis Care Res (Hoboken) (2014) 0.96
Spirituality, well-being, and quality of life in people with rheumatoid arthritis. Arthritis Rheum (2003) 0.95
Weight loss and health-related quality of life: results at 1-year follow-up. Eat Behav (2004) 0.95
Depressive symptoms and adherence to asthma therapy after hospital discharge. Chest (2006) 0.95
Assessment of myocardial abnormalities in rheumatoid arthritis using a comprehensive cardiac magnetic resonance approach: a pilot study. Arthritis Res Ther (2010) 0.95
Muscle density in rheumatoid arthritis: associations with disease features and functional outcomes. Arthritis Rheum (2012) 0.94
New directions for patient-centred care in scleroderma: the Scleroderma Patient-centred Intervention Network (SPIN). Clin Exp Rheumatol (2012) 0.94
Comparison of an in vitro tuberculosis interferon-gamma assay with delayed-type hypersensitivity testing for detection of latent Mycobacterium tuberculosis: a pilot study in rheumatoid arthritis. J Rheumatol (2008) 0.94
Myocardial citrullination in rheumatoid arthritis: a correlative histopathologic study. Arthritis Res Ther (2012) 0.94
Physical activity participation by presence and type of functional deficits in older women: The Women's Health and Aging Studies. J Gerontol A Biol Sci Med Sci (2006) 0.93
Updating the OMERACT filter: implications for patient-reported outcomes. J Rheumatol (2014) 0.92
Precision of the iDXA for visceral adipose tissue measurement in severely obese patients. Med Sci Sports Exerc (2014) 0.92
Proposal for levels of evidence schema for validation of a soluble biomarker reflecting damage endpoints in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis, and recommendations for study design. J Rheumatol (2009) 0.91
Population projection of US adults with lifetime experience of depressive disorder by age and sex from year 2005 to 2050. Int J Geriatr Psychiatry (2008) 0.91
The 2008 American College of Rheumatology recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis: where the rubber meets the road. Arthritis Rheum (2008) 0.91
Predicting exercise capacity through submaximal fitness tests in persons with multiple sclerosis. Arch Phys Med Rehabil (2010) 0.89
Respiratory symptoms and disease characteristics as predictors of pulmonary function abnormalities in patients with rheumatoid arthritis: an observational cohort study. Arthritis Res Ther (2010) 0.88